Sanofi will invest approximately €400 million annually in a vaccines mRNA Centre of Excellence. The centre will work to accelerate the development and delivery of next-generation vaccines by bringing together approximately 400 dedicated employees integrating end-to-end mRNA vaccine capabilities with dedicated R&D, digital, and chemistry, manufacturing and controls (CMC) teams… Read More
Mari Scheiffele is the General Manager for Oncology in the UK & Ireland at Novartis, responsible for launching innovative oncology therapies that can help to change the lives of people living with different types of cancer. She speaks to Lu Rahman about her passion for working with her teams to… Read More
Albany College of Pharmacy and Health Sciences has an opening for the Director of The Stack Family Centre for Biopharmaceutical Education and Training (CBET). CBET is an evolutionary leap in health sciences education and biomanufacturing workforce training. The CBET Director will be responsible for the development and creation of sustainable… Read More
Ahead of the return of CPhI North America, Informa Markets has commissioned an in-depth report into the US pharma market focusing on how the pandemic has affected public discourse and political priorities, and how it could alter the pharmaceutical supply paradigm in the medium term. Analysis from six leading US… Read More
The process of antibody discovery and development into a clinical candidate is one full of twists, turns and offshoots, yet one that an increasing number of researchers and companies, both small and large, have successfully navigated. This eBook released by Twist Biopharma is designed to be used as a… Read More
You’re about to embark on a journey of discovery. And like all journeys that are worthwhile, it’s far from linear. The process of antibody discovery and development into a clinical candidate is one full of twists, turns, roundabouts, and offshoots, yet one that an increasing number of researchers and companies,… Read More
Over recent years, interest in identifying new targets to modify an immune response to control a host of human diseases has sky-rocketed. Based in part on the success of several new immune cell targeted treatments for cancer, combined with the CRISPR-Cas revolution and the ability to culture primary immune cells… Read More
Scohia has presented the results of a Phase I clinical trial for SCO-267, an orally bioavailable GPR40 full agonist, at the Virtual Scientific Sessions of the American Diabetes Association. Free fatty acid receptor 1 (GPR40) is a G protein-coupled receptor expressed in pancreatic islet and enteroendocrine cells, and SCO-267 is… Read More
The President of the UK’s Association of the British Pharmaceutical Industry (ABPI) has announced that its 2021 Code of Practice puts new emphasis on the ABPI’s principles. “We want everyone in pharmaceutical companies to live and breathe these from leadership teams and commercial leads to admin assistants and research scientists. Read More
In this latest DDW whitepaper, brought to you by PerkinElmer Informatics, John Conway, is Chief Visioneer Officer at 20/15 Visioneers, tackles defining “What Makes a Great BioELN” in this thoughtful and informative industry perspective. The whitepaper covers the six high-level workflows a great BioELN must include; what the team personas… Read More
John Conway of 20/15 Visioneers tackles defining “What Makes a Great BioELN” in this thoughtful and informative industry perspective. Learn: The six high-level workflows a great BioELN must include What are the team personas who must get utility from a new BioELN The 3 key qualities necessary to have in… Read More
EQRx and Exscientia are collaborating to combine the AI capabilities of Exscientia to accelerate the discovery of small molecule therapeutic drug candidates and expand EQRx’s pipeline of novel therapies. This collaboration is focused on creating improvements in the traditional drug discovery and development processes by improving the probability of success… Read More
Takara Bio has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies. Takara Bio will grant BioNTech a commercial license to use applicable patents relating to RetroNectin, and will provide BioNTech with supplies of RetroNectin. The patented technologies licensed to BioNTech are based on Takara Bio’s… Read More
Sinocompound Catalysts has launched a video series sharing catalyst expertise. “The essentials in a synthetic chemist’s toolbox”, is the swork of Technical Advisor, Dr Carin Seechurn. The first episode is now live and focuses on palladium catalysed cross-coupling reactions. Over the last 20-30 years, hundreds of ligands have been reported… Read More
National Institutes of Health scientists and their collaborators have identified an internal communication network in mammals that may regulate tissue repair and inflammation, providing new insights on how diseases such as obesity and inflammatory skin disorders develop. The new research is published in Cell. The billions of organisms living on… Read More
GlaxoSmithKline has announced New GSK, which will deliver step-change in growth and performance over next ten years, driven by a high-quality Vaccines and Specialty Medicines portfolio and late-stage pipeline. New GSK will keep a 20% stake in the consumer healthcare business. The Independent confirmed: “The unit will be listed on… Read More
